Safety of fluoroquinolones 10 years later
Frías Iniesta, J.; Ibáñez Ruiz, C.; Esteban Calvo, C.
Revista Espanola de Quimioterapia Publicacion Oficial de la Sociedad Espanola de Quimioterapia 12(1): 34-40
1999
ISSN/ISBN: 0214-3429 PMID: 10209062 Document Number: 502168
Document emailed within 1 workday
Related Documents
Basu, I.; Supe, P.D.; Agarwal, M. 2020: Comparison of Immunogenicity and Safety between two Quadrivalent Influenza Vaccines in Healthy Indian Adults (18-60 Years) and Elderly (? 61 Years) - a Phase III, Active-Controlled, Randomized Clinical Study Journal of the Association of Physicians of India 68(1): 105Álvarez, J.; Paredes, R.M.; Cambra, F.J.; Vento, M.; López, M.; de Agustín, J.C.; Moral, M.T. 2017: More than three hours, less than three years. Safety of anesthetic procedures in children under three years, subject to surgeries of more than three hours Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 30(1): 3-8
Maroncelli, R.; Kaun-Till, G.; Rauber, A. 1984: Safety closures after fifteen years Veterinary and Human Toxicology 26(Suppl 2): 16-17
Grimes, D.A. 1992: The safety of oral contraceptives: epidemiologic insights from the first 30 years American Journal of Obstetrics and Gynecology 166(6 Part 2): 1950-1954
Anderson, T.L.; Vancaillie, T.G. 2011: The Adiana System for permanent contraception: safety and efficacy at 3 years Journal of Minimally Invasive Gynecology 18(5): 612-616
Constenla, I.R.; Pato, A.P.; Hernando, I.C.; Gonzalez, J.R.L. 2014: Safety and Tolerability of Transdermal Rotigotine in a Clinical Practice Cohort for 2 Years World Journal of Neuroscience 04(05): 443-449
Yang, B.Y. 1988: The long-term safety of use of the stainless steel IUD: over 20 years use. Clinical and pathological analysis Sheng Zhi Yu Bi Yun 8(2): 9-14
Yang, B.Y. 1988: The long-term safety of use of the stainless steel IUD: over 20 years use. Clinical and pathological analysis Sheng Zhi Yu Bi Yun 8(2): 9-14
Clamp, M.; Kendrick, D. 1998: A randomised controlled trial of general practitioner safety advice for families with children under 5 years BMJ 316(7144): 1576-1579
De Boeck, E.; Mortier, A.V.; Jacxsens, L.; Dequidt, L.; Vlerick, P. 2017: Towards an extended food safety culture model: Studying the moderating role of burnout and jobstress, the mediating role of food safety knowledge and motivation in the relation between food safety climate and food safety behavior Trends in Food Science and Technology 62: 202-214
Ferry, L.; Johnston, J.A. 2003: Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience International Journal of Clinical Practice 57(3): 224-230
Holmertz, V.; Mörk, C.; Stubbendorff, S.; Thomasson, J.; Trozell, M. 1987: Dialysis accidents--4 years after. Who takes responsibility when safety is lacking? Worried members interrupt work Vardfacket 11(22): 4-6
Damas, P. 1996: Fluoroquinolones Revue Medicale de Liege 51(1): 50-52
Huovinen, P.; Valtonen, V. 1988: Fluoroquinolones Duodecim; Laaketieteellinen Aikakauskirja 104(4): 229-238
Brody, T.; Pensak, M.L. 1991: The fluoroquinolones American Journal of Otology 12(6): 477-479
Tedeschi, R.E.; Martz, B.L.; Taylor, H.A.; Cerimelle, B.J. 1980: A long-term (9 years) clinical study of the safety and efficacy of probucol, and an analysis of morbidity and mortality rates La Nouvelle Presse Medicale 9(40): 3021-3027
Debois, H.; Loupi, E.; Saliou, P. 2002: Surveillance of the safety of intravesical BCG therapy in France: quantitative analysis of serious adverse events notified over a period of five years Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 12(4): 604-608
Guay, D.R. 1992: The role of the fluoroquinolones PharmacoTherapy 12(6 Part 2): 71s-85s
Zhang, Y. 1999: The rational use of fluoroquinolones Zhonghua Nei Ke Za Zhi 38(1): 7-8
Reich, K.; Papp, K.A.; Griffiths, C.E.M.; Szapary, P.O.; Yeilding, N.; Wasfi, Y.; Ott, E.; Hsu, M-Chun.; Lebwohl, M.; Gordon, K.B. 2012: An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up Journal of drugs in dermatology: JDD 11(3): 300-312